Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein
- 24 March 2010
- Vol. 28 (15) , 2754-2762
- https://doi.org/10.1016/j.vaccine.2010.01.030
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health Grant (AI057552)
This publication has 45 references indexed in Scilit:
- Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigsVaccine, 2008
- Selective Ablation of Virion Host Shutoff Protein RNase Activity Attenuates Herpes Simplex Virus 2 in MiceJournal of Virology, 2008
- Disruption of the UL41 gene in the herpes simplex virus 2 dl5-29 mutant increases its immunogenicity and protective capacity in a murine model of genital herpesVirology, 2008
- Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular diseaseVirology, 2007
- Interaction of herpes simplex virus RNase with VP16 and VP22 is required for the accumulation of the protein but not for accumulation of mRNAProceedings of the National Academy of Sciences, 2007
- Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studiesSexually Transmitted Infections, 2007
- Comparative Efficacy and Immunogenicity of Replication-Defective, Recombinant Glycoprotein, and DNA Vaccines for Herpes Simplex Virus 2 Infections in Mice and Guinea PigsJournal of Virology, 2005
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- Characterization of Herpes Simplex Virus Strains Differing in their Effects on Social Behaviour of Infected CellsJournal of General Virology, 1968